Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Cancer × IFL protocol × Clear all

Sponsor

Conditions

Colorectal Neoplasms 17 Rectal Neoplasms 7 Colonic Neoplasms 6 Neoplasms 3 Neoplasm Metastasis 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Gastrointestinal Neoplasms 1 Exanthema 1 Colorectal Cancer Metastatic 1 Carcinoma, Basal Cell 1 Advanced Solid Tumor 1 Adenocarcinoma 1

Interventions

Nivolumab 6 linrodostat 3 relatlimab 2 Pemetrexed 2 Ipilimumab 2 tislelizumab 1 regorafenib 1 ralimetinib 1 p38 Mitogen-Activated Protein Kinases 1 efatutazone 1 abemaciclib 1 Vorinostat 1 Tamoxifen 1 Ranitidine 1 Midazolam 1 LY2603618 1 LY2584702 1 Gemcitabine 1 Fulvestrant 1 Dasatinib 1 Crizotinib 1 Cetuximab 1 Carboplatin 1 BMS-813160 1 3-(9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-imidazo(1,2-a)pyridin-3-yl-1H-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡